Form 4: Applied Therapeutics CEO Sells Shares to Cover Tax Obligations

Applied Therapeutics CEO Shoshana Shendelman sold shares to cover tax withholding obligations related to the vesting and settlement of compensatory Restricted Stock Units.

Summary

• On June 6, 2024, Shoshana Shendelman, the President and CEO of Applied Therapeutics, Inc., sold 61,795 shares of common stock at a price of $4.32 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
• Following the transaction, Shendelman directly owns 3,756,019 shares of Applied Therapeutics common stock.
• She also indirectly owns shares through various trusts and entities, including a grantor retained annuity trust (1,750,000 shares), a family trust controlled by her spouse (1,492,094 shares), her spouse (709,720 shares), a family trust controlled by her (290,280 shares), and Clearpoint Strategy Group LLC (88,397 shares).

Sentiment

Score: 5

Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative. It's a neutral event in terms of investment sentiment.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This transaction is related to tax obligations and may not reflect a change in the CEO's long-term outlook for the company.

Key Dates